April 21st 2025, 7:00pm
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.
April 21st 2025, 5:00pm
Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.
April 21st 2025, 4:00pm
Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive metastatic breast cancer.
April 21st 2025, 3:00pm
In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.
April 21st 2025, 1:00pm
Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be recommended, a trial found.
April 20th 2025, 6:00pm
After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the face of chronic blood cancers.
April 20th 2025, 2:00pm
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.
April 19th 2025, 6:00pm
Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, according to the ROMEI clinical trial.
April 19th 2025, 2:00pm
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.
April 18th 2025, 9:21pm
Dr. Rugo has led key breast cancer therapy trials and exudes a passion for serving patients.
An Expert Offers Advice and Resources for Navigating Rare Lymphoma
Celebrating an Expert at Emotional Support
Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC
A Healer’s Touch During My Experience With Cancer Care
